Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Viking Therapeutics (VKTX) Return on Assets (2016 - 2025)

Viking Therapeutics (VKTX) has disclosed Return on Assets for 11 consecutive years, with 0.49% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 38.0% to 0.49% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.49% through Dec 2025, down 38.0% year-over-year, with the annual reading at 0.44% for FY2025, 27.0% down from the prior year.
  • Return on Assets hit 0.49% in Q4 2025 for Viking Therapeutics, down from 0.3% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.1% in Q2 2024 to a low of 0.49% in Q4 2025.
  • Historically, Return on Assets has averaged 0.25% across 5 years, with a median of 0.23% in 2021.
  • Biggest five-year swings in Return on Assets: skyrocketed 31bps in 2024 and later plummeted -38bps in 2025.
  • Year by year, Return on Assets stood at 0.25% in 2021, then tumbled by -62bps to 0.41% in 2022, then soared by 44bps to 0.23% in 2023, then surged by 48bps to 0.12% in 2024, then plummeted by -315bps to 0.49% in 2025.
  • Business Quant data shows Return on Assets for VKTX at 0.49% in Q4 2025, 0.3% in Q3 2025, and 0.2% in Q2 2025.